Please login to read the full article.
Scrip Regulatory Affairs
Saudi FDA updates guideline on device marketing authorisation procedures
09 December 2011
Vibha Sharma
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- GHTF consults on deleting "type examination" option from its revised conformity assessment guideline
- EU-wide consensus on confidential commercial data in drug marketing applications
- EU Commission proposes clinical evidence requirements for all IVDs except lowest-risk
- Delay in China's review time for drugs likely to continue; review predictability and transparency improve
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
